Membrane-Targeting Approaches for Enhanced Cancer Cell Destruction with Irreversible Electroporation
- 520 Downloads
Irreversible electroporation (IRE) is a promising technology to treat local malignant cancer using short, high-voltage electric pulses. Unfortunately, in vivo studies show that IRE suffers from an inability to destroy large volumes of cancer tissue without introduction of cytotoxic agents and/or increasing the applied electrical dose to dangerous levels. This research will address this limitation by leveraging membrane-targeting mechanisms that increase lethal membrane permeabilization. Methods that directly modify membrane properties or change the pulse delivery timing are proposed that do not rely on cytotoxic agents. This work shows that significant enhancement (67–75% more cell destruction in vitro and >100% treatment volume increase in vivo) can be achieved using membrane-targeting approaches for IRE cancer destruction. The methods introduced are surfactants (i.e., DMSO) and pulse timing which are low cost, non-toxic, and easy to be incorporated into existing clinical use. Moreover, when needed, these methods can also be combined with electrochemotherapy to further enhance IRE treatment efficacy.
KeywordsIrreversible electroporation Cancer treatment Adjuvant DMSO Pulse timing Membrane permeabilization
This study was supported by Ethicon Endo-Surgery Inc. We thank Peter Shires for helpful discussions. JCB was supported by a McKnight Distinguished Professorship and the Carl and Janet Kuhrmeyer Chair of Mechanical Engineering from the University of Minnesota.
- 4.Cheng, D. K. L., L. Tung, and E. A. Sobie. Nonuniform responses of transmembrane potential during electric field stimulation of single cardiac cells. Am. J. Physiol. Heart Circ. Physiol. 277(1):H351–H362, 1999.Google Scholar
- 7.Deodhar, A., T. Dickfeld, G. W. Single, W. C. Hamilton, R. H. Thornton, C. T. Sofocleous, M. Maybody, M. Gónen, B. Rubinsky, and S. B. Solomon. Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. AJR Am. J. Roentgenol. 196(3):W330–W335, 2011.PubMedCrossRefGoogle Scholar
- 21.Guo, Y., Y. Zhang, R. Klein, G. M. Nijm, A. V. Sahakian, R. A. Omary, G.-Y. Yang, and A. C. Larson. Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res. 70(4):1555–1563, 2010.PubMedCentralPubMedCrossRefGoogle Scholar
- 25.Long, G., G. Bakos, P. K. Shires, L. Gritter, J. W. Crissman, J. L. Harris, and J. W. Clymer. Histological and finite element analysis of cell death due to irreversible electroporation. TCRT Express, 2013.Google Scholar
- 36.Sersa, G., T. Jarm, T. Kotnik, A. Coer, M. Podkrajsek, M. Sentjurc, D. Miklavcic, M. Kadivec, S. Kranjc, A. Secerov, and M. Cemazar. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br. J. Cancer 98(2):388–398, 2008.PubMedCentralPubMedCrossRefGoogle Scholar
- 39.Tovar, O., and L. Tung. Electroporation and recovery of cardiac cell membrane with rectangular voltage pulses. Am. J. Physiol. Heart Circ. Physiol. 263(4):H1128–H1136, 1992.Google Scholar